This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
By This Author:
« Back
Page 1 of 150

Lessons Learned From the Hedge Fund Crisis

By Melissa Davis

Last year brought enough investor pain to reshape the entire industry.

02:55PM 02/20/09

Why There's Still Hope for Detroit

By Melissa Davis

David Cole, chairman of the Center for Automotive Research, believes there could be a happy ending for GM and Ford.

03:56PM 01/27/09

GM's Biggest Foe Could Be Time

By Melissa Davis

The automaker already has received union concessions, but shareholders face dilution over how GM reduces its debt load.

03:54PM 01/16/09

Humana's Learning to Change With the Times

By Melissa Davis

Even if Democrats manage to end its "private fee-for-service" business, the company's confident that everything will work out in the end.

03:00PM 12/05/08

Health Insurers See 'Universal' Opportunity

By Melissa Davis

Companies such as Humana and UnitedHealth could benefit if the Democrats institute universal health care.

01:02PM 11/24/08

Hospitals Face a Baby-Boom Bust

By Melissa Davis

For-profit providers face a tough road amid likely Medicare reforms.

01:48PM 11/12/08

Pickens Fueling Natural Gas Push

By Melissa Davis

The longtime oilman wants to cut our dependence on foreign oil.

01:53PM 11/04/08

Tenet Healthcare Shares Punished

By Melissa Davis

The company gets a little murkier on 2009.

12:43PM 11/04/08

GE Set for a Pickens Windfall

By Melissa Davis

The company stands to make out well if the oilman's alternative-energy plan moves forward.

02:05PM 11/03/08

CVS Slashes Generic Drug Prices

By Melissa Davis

The drugstore chain is coming out with a health care pass that will lower generic drug prices.

04:41PM 10/31/08

« Back
Page 1 of 150

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV


DOW 18,010.68 -115.44 -0.64%
S&P 500 2,107.39 -13.40 -0.63%
NASDAQ 5,070.0260 -27.95 -0.55%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs